Intermittent vs Continuous Pulse Oximetry in Hospitalized Infants With Stabilized Bronchiolitis: A Randomized Clinical Trial.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 2 3 2021
medline: 27 1 2022
entrez: 1 3 2021
Statut: ppublish

Résumé

There is low level of evidence and substantial practice variation regarding the use of intermittent or continuous monitoring in infants hospitalized with bronchiolitis. To compare the effect of intermittent vs continuous pulse oximetry on clinical outcomes. This multicenter, pragmatic randomized clinical trial included infants 4 weeks to 24 months of age who were hospitalized with bronchiolitis from November 1, 2016, to May 31, 2019, with or without supplemental oxygen after stabilization at community and children's hospitals in Ontario, Canada. Intermittent (every 4 hours, n = 114) or continuous (n = 115) pulse oximetry, using an oxygen saturation target of 90% or higher. The primary outcome was length of hospital stay from randomization to discharge. Secondary outcomes included length of stay from inpatient unit admission to discharge and outcomes measured from randomization: medical interventions, safety (intensive care unit transfer and revisits), parent anxiety and workdays missed, and nursing satisfaction. Among 229 infants enrolled (median [IQR] age, 4.0 [2.2-8.5] months; 136 [59.4%] male; 101 [44.1%] from community hospital sites), the median length of hospital stay from randomization to discharge was 27.6 hours (interquartile range [IQR], 18.8-49.6 hours) in the intermittent group and 25.4 hours (IQR, 18.3-47.6 hours) in the continuous group (difference of medians, 2.2 hours; 95% CI, -1.9 to 6.3 hours; P = .17). No significant differences were observed between the intermittent and continuous groups in the median length of stay from inpatient unit admission to discharge: 49.1 (IQR, 37.2-87.0) hours vs 46.0 (IQR, 32.5-73.8) hours (P = .13) or in frequencies or durations of hospital interventions, such as oxygen supplementation initiation: 4 of 114 (3.5%) vs. 9 of 115 (7.8%) (P = .16) and median duration of oxygen supplementation: 20.6 (IQR, 7.6-46.1) hours vs. 21.4 (11.6-52.9) hours (P = .66). Similarly, there were no significant differences in frequencies of intensive care unit transfer: 1 of 114 (0.9%) vs 2 of 115 (2.7%) (P = .76); readmission to hospital: 3 of 114 (2.6%) in the intermittent group vs 4 of 115 (3.5%) in the continuous group (P > .99); parent anxiety: mean (SD) parent anxiety score, 2.9 (0.9) in the intermittent group vs 2.8 (0.9) in the continuous group (P = .40); or parent workdays missed: median workdays missed, 1.5 (IQR, 0.5-3.0) vs 1.5 (IQR, 0.5-2.5) (P = .36). Mean (SD) nursing satisfaction with monitoring was significantly greater in the intermittent group: 8.6 (1.7) vs 7.1 (2.8) of 10 workdays; the mean difference was 1.5 (95% CI, 0.9-2.2; P < .001). In this randomized clinical trial, among infants hospitalized with stabilized bronchiolitis with and without hypoxia and managed using an oxygen saturation target of 90% or higher, clinical outcomes, including length of hospital stay and safety, were similar with intermittent vs continuous pulse oximetry. Nursing satisfaction was greater with intermittent monitoring. Given that other important clinical practice considerations favor less intense monitoring, these findings support the standard use of intermittent pulse oximetry in stable infants hospitalized with bronchiolitis. ClinicalTrials.gov Identifier: NCT02947204.

Identifiants

pubmed: 33646286
pii: 2776775
doi: 10.1001/jamapediatrics.2020.6141
pmc: PMC7922227
doi:

Banques de données

ClinicalTrials.gov
['NCT02947204']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-474

Subventions

Organisme : CIHR
ID : PJT-148635
Pays : Canada

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Sanjay Mahant (S)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Gita Wahi (G)

Division of General Pediatrics, Department of Pediatrics, McMaster University and McMaster Children's Hospital, Hamilton, Ontario, Canada.

Ann Bayliss (A)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Children's Health Division, Trillium Health Partners, Mississauga, Ontario, Canada.

Lucy Giglia (L)

Division of General Pediatrics, Department of Pediatrics, McMaster University and McMaster Children's Hospital, Hamilton, Ontario, Canada.

Ronik Kanani (R)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
North York General Hospital, Toronto, Ontario, Canada.

Catherine M Pound (CM)

Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.

Mahmoud Sakran (M)

Department of Pediatrics, Queens University, Kingston, Ontario, Canada.
Department of Pediatrics, Lakeridge Health, Oshawa, Ontario, Canada.

Natascha Kozlowski (N)

Department of Pediatrics, Lakeridge Health, Oshawa, Ontario, Canada.

Karen Breen-Reid (K)

Learning Institute, Hospital for Sick Children and Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.

Dana Arafeh (D)

Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Myla E Moretti (ME)

Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Ontario Child Health Support Unit, SickKids Research Institute, Toronto, Ontario, Canada.

Amisha Agarwal (A)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Nick Barrowman (N)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Andrew R Willan (AR)

Ontario Child Health Support Unit, SickKids Research Institute, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Suzanne Schuh (S)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Patricia C Parkin (PC)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH